Federal contract award
75D30121P11466
RENEWAL OF DNASTAR LASERGENE BIOLOGY SUITE SITE LICENSE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 511210 |
| PSC | 7A21 — Business Application off-the-shelf software delivered by perpetual license, which also encompasses enterprise level software enabling mission capability and business operational support. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $85.5K |
| Current contract value | $85.5K |
| Potential contract value / ceiling | $142.5K |
| Start date | Sep 19, 2021 |
| Current end date | Sep 18, 2024 |
| Potential end date | Sep 18, 2026 |
| Latest award activity | Jun 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 9, 2026 | P00003 | $0 | EO 14398 |
| Sep 15, 2023 | P00002 | $28.5K | RENEWAL OF DNASTAR LASERGENE BIOLOGY SUITE SITE LICENSE |
| Mar 29, 2022 | P00001 | $28.5K | RENEWAL OF DNASTAR LASERGENE BIOLOGY SUITE SITE LICENSE |
| Jul 2, 2021 | 0 | $28.5K | RENEWAL OF DNASTAR LASERGENE BIOLOGY SUITE SITE LICENSE |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Lenore Mickle | Contact | emickle@cdc.gov 4707854608 | Source | May 10, 2021 |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.